AMERICAN REALTY INVESTORS IN (ARL)

US0291741090 - Common Stock

13.78  0 (0%)

After market: 13.78 0 (0%)

Fundamental Rating

3

Overall ARL gets a fundamental rating of 3 out of 10. We evaluated ARL against 66 industry peers in the Real Estate Management & Development industry. The financial health of ARL is average, but there are quite some concerns on its profitability. ARL is valued expensive and it does not seem to be growing.



3

1. Profitability

1.1 Basic Checks

ARL had positive earnings in the past year.
ARL had a negative operating cash flow in the past year.
Of the past 5 years ARL 4 years were profitable.
In the past 5 years ARL reported 4 times negative operating cash flow.

1.2 Ratios

The Return On Assets of ARL (0.39%) is better than 63.08% of its industry peers.
The Return On Equity of ARL (0.64%) is better than 61.54% of its industry peers.
Industry RankSector Rank
ROA 0.39%
ROE 0.64%
ROIC N/A
ROA(3y)10.66%
ROA(5y)6.22%
ROE(3y)20.96%
ROE(5y)12%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

ARL's Profit Margin of 7.88% is fine compared to the rest of the industry. ARL outperforms 80.00% of its industry peers.
ARL's Profit Margin has declined in the last couple of years.
The Gross Margin of ARL (44.86%) is better than 81.54% of its industry peers.
In the last couple of years the Gross Margin of ARL has declined.
Industry RankSector Rank
OM N/A
PM (TTM) 7.88%
GM 44.86%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-19.84%
PM growth 5Y-44.01%
GM growth 3Y-8.7%
GM growth 5Y-2.48%

5

2. Health

2.1 Basic Checks

ARL does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ARL has been reduced compared to 1 year ago.
The number of shares outstanding for ARL has been increased compared to 5 years ago.
The debt/assets ratio for ARL has been reduced compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 1.24, we must say that ARL is in the distress zone and has some risk of bankruptcy.
ARL has a Altman-Z score (1.24) which is in line with its industry peers.
ARL has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
ARL has a Debt to Equity ratio of 0.30. This is comparable to the rest of the industry: ARL outperforms 58.46% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Altman-Z 1.24
ROIC/WACCN/A
WACC7.9%

2.3 Liquidity

ARL has a Current Ratio of 9.19. This indicates that ARL is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 9.19, ARL belongs to the best of the industry, outperforming 89.23% of the companies in the same industry.
ARL has a Quick Ratio of 9.19. This indicates that ARL is financially healthy and has no problem in meeting its short term obligations.
ARL has a better Quick ratio (9.19) than 92.31% of its industry peers.
Industry RankSector Rank
Current Ratio 9.19
Quick Ratio 9.19

1

3. Growth

3.1 Past

ARL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -98.97%.
Measured over the past years, ARL shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -53.09% on average per year.
Looking at the last year, ARL shows a very strong growth in Revenue. The Revenue has grown by 34.53%.
The Revenue for ARL have been decreasing by -16.03% on average. This is quite bad
EPS 1Y (TTM)-98.97%
EPS 3Y-24.02%
EPS 5Y-53.09%
EPS growth Q2Q-104.89%
Revenue 1Y (TTM)34.53%
Revenue growth 3Y-5.05%
Revenue growth 5Y-16.03%
Revenue growth Q2Q5.62%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 57.42 indicates a quite expensive valuation of ARL.
Based on the Price/Earnings ratio, ARL is valued a bit cheaper than 63.08% of the companies in the same industry.
ARL's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 28.06.
Industry RankSector Rank
PE 57.42
Fwd PE N/A

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as ARL.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 112.34

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ARL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AMERICAN REALTY INVESTORS IN

NYSE:ARL (5/2/2024, 7:04:00 PM)

After market: 13.78 0 (0%)

13.78

0 (0%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap222.55M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 57.42
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.39%
ROE 0.64%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) 7.88%
GM 44.86%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 9.19
Quick Ratio 9.19
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-98.97%
EPS 3Y-24.02%
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)34.53%
Revenue growth 3Y-5.05%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y